LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-β–Induced Angiogenesis
Quan Hong(Chinese PLA General Hospital), Kyung Lee(Icahn School of Medicine at Mount Sinai), Detlef Schlöndorff(Suzuki (Japan)), Girish N. Nadkarni(Icahn School of Medicine at Mount Sinai), Jia Fu(Harbin Medical University), Kinsuk Chauhan(Icahn School of Medicine at Mount Sinai), Guangyan Cai(Chinese PLA General Hospital), Steven G. Coca(Icahn School of Medicine at Mount Sinai), Matthias Kretzler(University of Michigan), Zhengzhe Li(Gannan Medical University), Wenjun Ju(Xuzhou Medical College), Lu Zhang(Xiamen University), Xiangmei Chen(State Administration of Traditional Chinese Medicine of the People's Republic of China), John Cijiang He(James J. Peters VA Medical Center), Vivette D. D’Agati(Columbia University), Divya Anna Verghese(Icahn School of Medicine at Mount Sinai)
Cited by 149
Related Papers
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
|Nature Biotechnology|2006|2.2k
Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices
|Kidney International|2018|1k
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
The immune cell landscape in kidneys of patients with lupus nephritis
|Nature Immunology|2019|840